Kate McKinley
Corporate Officer/Principal at RANI THERAPEUTICS HOLDINGS, INC.
Net worth: - $ as of 2024-04-29
Profile
Kate McKinley is currently the Director at Maxwell Biosciences, Inc. and the Chief Business Officer at Rani Therapeutics Holdings, Inc. Previously, she was the Chief Executive Officer & Director at Elevar Therapeutics, Inc. from 2019 to 2022.
She also held a position as Head-Marketing, Training & Hospital Channel at Dendreon Pharmaceuticals LLC.
Ms. McKinley received an undergraduate degree from The University of Tulsa and an MBA from Collins College of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-20 | 0 ( -.--% ) | - $ | 2024-04-29 |
Kate McKinley active positions
| Companies | Position | Start |
|---|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | Corporate Officer/Principal | 2023-05-23 |
Maxwell Biosciences, Inc.
 Maxwell Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Maxwell Biosciences, Inc. operates as biotechnology company for optimizing cognitive performance and health span. The company was founded by Joshua McClure and Annelise Barron in 2016 and is headquartered in Austin, TX. | Director/Board Member | 2022-11-06 |
Former positions of Kate McKinley
| Companies | Position | End |
|---|---|---|
Elevar Therapeutics, Inc.
 Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Chief Executive Officer | 2022-06-30 |
Dendreon Pharmaceuticals LLC
 Dendreon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Dendreon Pharmaceuticals LLC is a commercial-stage biopharmaceutical company that specializes in developing, manufacturing, and commercializing cell therapies. Dendreon Pharmaceuticals is based in Seal Beach, CA. The private company is a pioneer in cellular therapy, targeting cancer and transforming lives. Dendreon has proven expertise in cellular therapy and ensures product quality through its experience in the field. The company was founded in 1992 by Edgar G. Engleman and Samuel Strober, and the CEO is John C O'Neill. | Corporate Officer/Principal | - |
Training of Kate McKinley
| The University of Tulsa | Undergraduate Degree |
| Collins College of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
Dendreon Pharmaceuticals LLC
Dendreon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Dendreon Pharmaceuticals LLC is a commercial-stage biopharmaceutical company that specializes in developing, manufacturing, and commercializing cell therapies. Dendreon Pharmaceuticals is based in Seal Beach, CA. The private company is a pioneer in cellular therapy, targeting cancer and transforming lives. Dendreon has proven expertise in cellular therapy and ensures product quality through its experience in the field. The company was founded in 1992 by Edgar G. Engleman and Samuel Strober, and the CEO is John C O'Neill. | Health Technology |
Maxwell Biosciences, Inc.
Maxwell Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Maxwell Biosciences, Inc. operates as biotechnology company for optimizing cognitive performance and health span. The company was founded by Joshua McClure and Annelise Barron in 2016 and is headquartered in Austin, TX. | Commercial Services |
- Stock Market
- Insiders
- Kate McKinley
